142 related articles for article (PubMed ID: 3605853)
1. Efficacy of sucralfate in preventing peptic ulceration induced by nonsteroidal anti-inflammatory drugs.
Hardin CK; Sexton CR; Peoples JB
Am Surg; 1987 Jul; 53(7):373-6. PubMed ID: 3605853
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
Dajani EZ; Agrawal NM
J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of famotidine in the healing of active benign gastric ulceration: comparison of nonsteroidal anti-inflammatory- or aspirin-induced gastric ulcer and idiopathic gastric ulceration. Long Island Jewish Medical Center Acid-Peptic Study Group.
Bank S; Blumstein M; Greenberg RE; Magier D; Lavin PT
Clin Ther; 1993; 15(1):36-45. PubMed ID: 8458053
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfate.
Lazzaroni M; Sainaghi M; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S48-53. PubMed ID: 10379470
[TBL] [Abstract][Full Text] [Related]
5. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
6. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
Miglioli M; Bianchi Porro G; Vaira D; Menegatti M; Brunetti G; Petrillo M; Ardizzone S; Frizziero L; Montrone F; Grandinetti G
Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419
[TBL] [Abstract][Full Text] [Related]
7. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
[TBL] [Abstract][Full Text] [Related]
8. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
9. Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs.
Levine LR; Cloud ML; Enas NH
Arch Intern Med; 1993 Nov; 153(21):2449-54. PubMed ID: 8215749
[TBL] [Abstract][Full Text] [Related]
10. NSAID-induced mucosal injury.
Liebowitz D
J Clin Gastroenterol; 1988 Dec; 10(6):609-11. PubMed ID: 3230276
[TBL] [Abstract][Full Text] [Related]
11. [Ulcer prevention during anti-rheumatism therapy and in intensive medicine].
Koelz HR
Schweiz Rundsch Med Prax; 1994 Jun; 83(25-26):768-71. PubMed ID: 8029591
[TBL] [Abstract][Full Text] [Related]
12. Gastroduodenal damage due to drugs, alcohol and smoking.
Domschke S; Domschke W
Clin Gastroenterol; 1984 May; 13(2):405-36. PubMed ID: 6378444
[TBL] [Abstract][Full Text] [Related]
13. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
Lanza F; Peace K; Gustitus L; Rack MF; Dickson B
Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
15. Role of cytoprotectants and nitric oxide inhibition in nonsteroidal anti-inflammatory drug-induced gastroduodenal injury in the rat.
Turner PV; Albassam MA; Percy DH; Lillie LE; Macallum GE
Comp Med; 2000 Apr; 50(2):140-6. PubMed ID: 10857004
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract.
Hirschowitz BI
Gastroenterologist; 1994 Sep; 2(3):207-23. PubMed ID: 7987619
[TBL] [Abstract][Full Text] [Related]
17. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
[TBL] [Abstract][Full Text] [Related]
18. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
Yeomans ND
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
[TBL] [Abstract][Full Text] [Related]
19. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
20. Comparison of nitric oxide-releasing NSAID and vitamin C with classic NSAID in healing of chronic gastric ulcers; involvement of reactive oxygen species.
Brzozowski T; Kwiecień S; Konturek PC; Konturek SJ; Mitis-Musiol M; Duda A; Bielański W; Hahn EG
Med Sci Monit; 2001; 7(4):592-9. PubMed ID: 11433182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
